Aytu BioPharma Inc. (AYTU)
NASDAQ · Healthcare
Aytu BioPharma Inc. Net Income 2014–2025
Aytu BioPharma Inc. annual/quarterly net income history and growth rate from 2014 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Aytu BioPharma Inc. net income for the quarter ending March 31, 2026 was -5.6 M, a 240.66% decrease year-over-year.
- Aytu BioPharma Inc. net income for the twelve months ending March 31, 2026 was -10.2 M, a 1112.19% increase year-over-year.
- Aytu BioPharma Inc. annual net income for 2025 was -13.6 M, a 14.40% decrease from 2024.
- Aytu BioPharma Inc. annual net income for 2024 was -15.8 M, a 7.08% decrease from 2023.
- Aytu BioPharma Inc. annual net income for 2023 was -17.1 M, a 84.33% decrease from 2022.
- Aytu BioPharma Inc. annual net income for 2022 was -108.8 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Aytu BioPharma Inc. Net Income — FAQ
Aytu BioPharma Inc. (AYTU) net income over the last 12 years — annual and quarterly figures with year-over-year growth and charts.
What is Aytu BioPharma Inc.'s net income?
Aytu BioPharma Inc. (AYTU) reported net income of -$14M for fiscal 2025.
Where can I see AYTU's net income history?
The chart and table above show Aytu BioPharma Inc.'s net income by year and by quarter, including the growth rate.